Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - Neon Therapeutics, Inc. | exhibit321.htm |
| EX-31.2 - EXHIBIT 31.2 - Neon Therapeutics, Inc. | exhibit312.htm |
| EX-31.1 - EXHIBIT 31.1 - Neon Therapeutics, Inc. | exhibit311.htm |
| EX-21.1 - EXHIBIT 21.1 - Neon Therapeutics, Inc. | exhibit211.htm |
| EX-10.14 - EXHIBIT 10.14 - Neon Therapeutics, Inc. | exhibit1014.htm |
| EX-4.3 - EXHIBIT 4.3 - Neon Therapeutics, Inc. | exhibit43.htm |
| 10-K - 10-K - Neon Therapeutics, Inc. | ntgn-201910xk.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-225937 and 333-230198) of Neon Therapeutics, Inc. of our report dated March 2, 2020 relating to the financial statements which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 2, 2020